Leap Therapeutics +3% as Valence Helix discloses 10.99% stake

|About: Leap Therapeutics, Inc. (LPTX)|By:, SA News Editor

Leap Therapeutics (NASDAQ:LPTX) is up 3% postmarket after a disclosure from Valence Helix that it's acquired a 10.99% stake.

Valence Helix and affiliates built the stake as part of a recent share offering at the beginning of February.

The filing doesn't allude to any activist plans.

Subscribe for full text news in your inbox